Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ok-Kyong Chaekal"'
Autor:
Markus Plate, Thomas J. Walsh, Koen van Besien, Sebastian Mayer, Alexandra Gomez-Arteaga, Alex Drelick, Hanna Rennert, Michael J. Satlin, Tsiporah B. Shore, Ok-Kyong Chaekal, Catherine B. Small, Rosemary Soave, Zhengming Chen, Rosy Priya L. Kodiyanplakkal, Jingmei Hsu, Nina Orfali, Adrienne A. Phillips
Publikováno v:
Leukemia & Lymphoma. 63:435-442
The incidence of adenovirus viremia and the role of screening in preventing adenovirus disease in adult transplant recipients are not well defined. Between January 2017 and May 2020, 262 allogeneic transplants were performed using in vivo T-cell depl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75455fbb6b85abb032bb85556a9df564
https://doi.org/10.1080/10428194.2021.1978088
https://doi.org/10.1080/10428194.2021.1978088
Autor:
Chandni Patel, Michelle Pasciolla, Rachel Abramova, David Salerno, Alexandra Gomez-Arteaga, Tsiporah B. Shore, Nina Orfali, Sebastian Mayer, Jingmei Hsu, Adrienne A. Phillips, Ok-Kyong Chaekal, Michael J. Satlin, Rosemary Soave, Rosy Priya L. Kodiyanplakkal, Alexander Drelick, Markus Plate, Koen Van Besien
Publikováno v:
Transplantation and cellular therapy.
Epstein-Barr virus (EBV) reactivation and EBV-related post-transplantation lymphoproliferative disorder (PTLD) are often fatal complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The risk of EBV reactivation may be mit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd63f847b0fd64da4388753ba7270962
https://pubmed.ncbi.nlm.nih.gov/36334653
https://pubmed.ncbi.nlm.nih.gov/36334653
Autor:
Ljiljana V. Vasovic, Robert A. DeSimone, Marilyn T Nedumcheril, Ok-Kyong Chaekal, Sabrina E Racine-Brzostek
Publikováno v:
Journal of Blood Medicine
Daratumumab, a monoclonal antibody therapeutic, is highly efficacious and widely used in all stages of multiple myeloma and amyloidosis and has promising activity in other hematologic disorders. Daratumumab interacts with red blood cells, interfering
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f492ccc6294d4a0bc8d3921df13e87
https://doi.org/10.2147/jbm.s213510
https://doi.org/10.2147/jbm.s213510
Autor:
Ok-Kyong, Chaekal, Rosemary, Soave, Zhengming, Chen, Tsiporah, Shore, Sebastian, Mayer, Adrienne, Phillips, Jing, Mei Hsu, Alexandra, Gomez-Arteaga, Hanna, Rennert, Alex, Drelick, Nina, Orfali, Thomas J, Walsh, Catherine B, Small, Rosy Priya L, Kodiyanplakkal, Markus, Plate, Michael J, Satlin, Koen, van Besien
Publikováno v:
Leukemialymphoma. 63(2)
The incidence of adenovirus viremia and the role of screening in preventing adenovirus disease in adult transplant recipients are not well defined. Between January 2017 and May 2020, 262 allogeneic transplants were performed using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e449a2410152fd857a57e372e240353e
https://pubmed.ncbi.nlm.nih.gov/34643477
https://pubmed.ncbi.nlm.nih.gov/34643477
Autor:
Ok-kyong Chaekal, Alexandra Gomez-Arteaga, Zhengming Chen, Rosemary Soave, Tsiporah Shore, Sebastian Mayer, Adrienne Phillips, Jing Mei Hsu, Alexander Drelick, Rosy Priya L. Kodiyanplakkal, Markus Plate, Michael J. Satlin, Koen van Besien
Publikováno v:
Transplantation and Cellular Therapy. 28:618.e1-618.e10
Covid-19 vaccination is recommended in allogeneic transplant recipients, but many questions remain regarding its efficacy. Here we studied serologic responses in 145 patients who had undergone allogeneic transplantation using in vivo T-cell depletion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d7bc1ce9a68f283d3ad7a381da3a1f8
https://doi.org/10.1016/j.jtct.2022.06.012
https://doi.org/10.1016/j.jtct.2022.06.012
Autor:
Jing Mei Hsu, Eric von Hofe, Yen-Michael Hsu, Jae-Hung Shieh, Ok-Kyong Chaekal, Danielle Guarneri, Thomas J. Fahey, Jana Ivanidze, Janusz Puc, Karrie Du, Ashlee You, Theresa Scognamiglio, Ljiljana Vasovic, Melissa Cushing, Moonsoo Jin, Koen Van Besien
Publikováno v:
Journal of Clinical Oncology. 40:6093-6093
6093 Background: ICAM-1 is a cell surface glycoprotein that is typically expressed on endothelial cells and immune cells and a ligand for LFA-1 integrin. It is also overexpressed in several malignancies, in particular anaplastic and advanced thyroid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb8a6ad52a17e317ce8b1314a70132aa
https://doi.org/10.1200/jco.2022.40.16_suppl.6093
https://doi.org/10.1200/jco.2022.40.16_suppl.6093
Autor:
Andromachi Scaradavou, Sebastian Mayer, Adrienne A. Phillips, Cynthia Romeo, Tsiporah B. Shore, Usama Gergis, Ok-Kyong Chaekal, Melissa M. Cushing, Sangmin Lee, Ludy Dobrila, Ellen K. Ritchie, Maria S. Albano, Gail J. Roboz, Jingmei Hsu, Danielle Guarneri, Emeline Masson Frenet, Koen van Besien, Michael Samuel, Pinkal Desai, Nina Orfali
Publikováno v:
Blood Adv
We conducted a prospective evaluation of cord blood (CB)–derived adoptive cell therapy, after salvage chemotherapy, for patients with advanced myeloid malignancies and poor prognosis. Previously, we reported safety, feasibility, and preliminary eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f22349807b895dab6215556e7eb52017
https://europepmc.org/articles/PMC7594383/
https://europepmc.org/articles/PMC7594383/
Publikováno v:
Follicular Lymphoma ISBN: 9783030262105
Despite major advances in the treatment of follicular lymphoma, the disease generally remains incurable. Novel targeted agents often require prolonged or continuous administration with issues of cost, compliance, and cumulative toxicity. Autologous s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8300606cded9982565b88adc1230c95
https://doi.org/10.1007/978-3-030-26211-2_9
https://doi.org/10.1007/978-3-030-26211-2_9
Autor:
Yen-Michael S. Hsu, Ok-Kyong Chaekal, Rosemary Soave, Michael J. Satlin, Hanna Rennert, Alexander Christian Drelick, Markus Plate, Koen van Besien, Thomas J. Walsh, Adrienne A. Phillips, Alexandra Gomez-Arteaga, Catherine B. Small, Jingmei Hsu, Rosy Priya Kodiyanplakkal, Tsiporah B. Shore, Sebastian Mayer
Publikováno v:
Transplantation and Cellular Therapy. 27:S370-S371
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da35e7dc76ae7314c90f6546104d978e
https://doi.org/10.1016/s2666-6367(21)00477-2
https://doi.org/10.1016/s2666-6367(21)00477-2
Autor:
Koen van Besien, Ok-Kyong Chaekal
Publikováno v:
Leuk Lymphoma
While TKI are the preferred first-line treatment for chronic phase (CP) CML, alloHCT remains an important consideration. The aim is to estimate residual life expectancy (RLE) for patients initially diagnosed with CP CML based on timing of alloHCT or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85d1bcd455a75aad24438800c23391f
https://doi.org/10.1080/10428194.2020.1817444
https://doi.org/10.1080/10428194.2020.1817444